AI speeds discovery, but unclear patent rights for AI-designed drugs threaten exclusivity, returns, and drug-development economics.

Medra, a developer of AI-powered lab robots and scientists to advance drug discovery, raises $52M - SiliconANGLE ...

Generative artificial intelligence is moving from the margins of pharma into the center of how new medicines are imagined, ...

Drug discovery is a high-risk, high-cost endeavor, with over 90% of candidates failing in clinical development. A significant proportion of these failures stem from unresolved biopharmaceutic ...

This segment of drug discovery and development involves leveraging artificial intelligence to automate various tasks, including information collection, drug design, pre-clinical trial planning, and ...

The rapid advancement of artificial intelligence (AI) is transforming the field of structural biology. In May 2024, DeepMind and Isomorphic Labs launched AlphaFold 3 (AF3), a revolutionary AI system ...

In a university lab, an AI system generated millions of novel molecules to fight drug-resistant infections. And they’re ...

Discover what the next wave of AI-assisted drug discovery looks like and how it can help biotech - the AI and physics combo.

This figure illustrates three key applications of AI in antimicrobial drug development: (1) target identification and validation, including novel target discovery, affinity prediction, multi-target ...

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant ...

The U.S. Department of Health and Human Services (HHS or Department) on Dec. 4, 2025, released its 21-page artificial intelligence (AI) strategy as ...